The Cancer

Don't Miss

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

Vital Information

Facts

Latest Articles

FDA Accepts Ivonescimab Software for EGFR Lung Most cancers

The U.S. Meals and Drug Administration (FDA) has accepted for submitting a biologics license utility from Summit Therapeutics in search of approval...

Key GI Most cancers Advances from the 2026 ASCO Symposium

This years 2026 ASCO Gastrointestinal Cancers Symposium was full of practice-shaping knowledge throughout colorectal and higher gastrointestinal malignancies, in line with Dr....

Ibrance Provides 15 Months of Development-Free Survival in HR+, HER2+ Breast Most cancers

Researchers from the Dana-Farber Most cancers Institute and worldwide analysis teams have revealed information in The New England Journal of Drugs exhibiting...

Threat Evaluation Stays Important for Sufferers Even After Most cancers Prognosis

In an interview with CURE, Dr. Elias Obeid, a medical oncologist at Hackensack College Medical Middle, mentioned the significance of threat evaluation...

Biotin, Lab Interference and Safer Choices for Most cancers-Associated Hair Loss

Hair modifications associated to most cancers remedy can lead sufferers to discover dietary supplements that promise regrowth or strengthening, ceaselessly with out...

Hot Topics